DXCM241122P61000
- 0.25
- 0.000.00%
DexCom Newsroom
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
DexCom, Inc. (DXCM): Innovation and Growth Catalysts Amid Strong Long-Term Outlook for Diabetes Care
BofA Securities Maintains DexCom(DXCM.US) With Buy Rating
Australia Diabetes Market Forecasts and Company Analysis 2024-2032, Novo Nordisk, Eli Lilly, Roche, Abbott Laboratories, Insuletn, Dexcom, Medtronic, Ypsomed
S&P 500, Dow Hit Records Right After Open | Live Stock
Bank of America Securities Reaffirms Their Buy Rating on Dexcom (DXCM)
Express News | Dexcom Inc : Leerink Partners Cuts Target Price to $86 From $87
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Market Climbs, Bitcoin Close to $100k | Live Stock
Here's Why DexCom (DXCM) Declined In Q3
DexCom and OURA Ink Partnership for Metabolic Health Innovation
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Nvidia Forward Guidance Was Not Perfect, Market Flat | Wall Street Today
Market Falls on Retail Results, Bitcoin Swells, All Eyes on Nvidia | Live Stock
Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $90
Wells Fargo Sticks to Its Buy Rating for Dexcom (DXCM)
Bitcoin Climbs to Fresh High, Market Shifts into Climb | Wall Street Today
These 10 Laggard Stocks Could Get Hit Further by Tax-Loss Selling